Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.
Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study.
Large-eddy simulation, convective instability, and modal causality of coaxial supersonic air–water jets considering a swirl effect.
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial.
Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis.
A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.